Overview of Lamotrigine and the New Antiepileptic Drugs: The Challenge
Author:
- 1 November 1997
- journal article
- other
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 12 (1_suppl) , S48-S52
Abstract
Lamotrigine, like all antiepileptic drugs, can be effective when used as monotherapy or adjunctive therapy. In general, adverse effects are reduced when monotherapy is employed. The most frequent adverse effect prompting withdrawal of lamotrigine is rash. This potentially life-threatening adverse effect occurs more frequently in children, is increased when a rapid dose titration schedule is employed, and is greater when lamotrigine is prescribed in combination with valproate. The availability of lamotrigine and other antiepileptic drugs represents a major advance for the treatment of childhood epilepsy. The challenge in using all of the new antiepileptic drugs, including lamotrigine, is to balance the expected improved efficacy with the potentially serious adverse effects. (J Child Neurol 1997;12(Suppl 1):S48-S52).Keywords
This publication has 10 references indexed in Scilit:
- Lamotrigine trial in idiopathic parkinsonismNeurology, 1997
- Reappraisal of Polytherapy in Epilepsy: A Critical Review of Drug Load and Adverse EffectsEpilepsia, 1997
- Lamotrigine in childhood epilepsiesSeminars in Pediatric Neurology, 1997
- New antiepileptic drugs in children: Present and futureSeminars in Pediatric Neurology, 1997
- Lamotrigine Adjunctive Therapy in Childhood Epileptic Encephalopathy (the Lennox Gastaut Syndrome)Epilepsia, 1997
- Diagnosis and Treatment of Epilepsy in Children and AdolescentsDrugs, 1996
- LamotrigineDrugs, 1995
- Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsyThe Lancet, 1995
- Intractable Epilepsy in Children. The Efficacy of Lamotrigine Treatment, Including Non-Seizure-Related BenefitsNeuropediatrics, 1994
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994